These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 1300931)
1. [Effectiveness of phosphomycin and its combinations with amikacin and cefotaxime in experimental plague infection]. Shcherbaniuk AI; Kasatkina IV; Makarovskaia LN Antibiot Khimioter; 1992 Nov; 37(11):29-30. PubMed ID: 1300931 [TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of cefotaxime in experimental plague infection]. Makarovskaia LN; Shcherbaniuk AI; Kasatkina IV; Zurabian VA Antibiot Khimioter; 1992 Nov; 37(11):24-6. PubMed ID: 1300929 [TBL] [Abstract][Full Text] [Related]
3. [Combined use of quinolones with other antibiotics in treatment of experimental plague infection]. Shcherbaniuk AI; Kasatkina IV; Ryzhko IV Antibiot Khimioter; 1994 May; 39(5):38-40. PubMed ID: 7857159 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of azlocillin and its combinations with other antibiotics in experimental plague infection]. Markovskaia EI; Makarovskaia LN; Ryzhkova VV; Zurabian VA Antibiot Khimioter; 1993 Jul; 38(7):37-9. PubMed ID: 8161276 [TBL] [Abstract][Full Text] [Related]
5. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe]. Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358 [TBL] [Abstract][Full Text] [Related]
6. [Prophylactic and therapeutic action of ceftazidime in comparison to that of cefotaxime and combined use of cefotaxime with other antibiotics in experimental plague of albino mice]. Zurabian VA; Markovskaia EI; Ryzhkova VV; Makarovskaia LN Antibiot Khimioter; 1994; 39(9-10):40-4. PubMed ID: 7695449 [TBL] [Abstract][Full Text] [Related]
7. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague]. Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325 [TBL] [Abstract][Full Text] [Related]
8. [Detoxifying effect of antibiotics and their effectiveness in experimental plague at the stage of explicit intoxication]. Makarovskaia LN; Glian'ko EV; Tinker LA; Kasatkin IuA; Ryzhkova VV; Bozhko NV; Kozyreva LA Antibiot Khimioter; 1992 Nov; 37(11):30-2. PubMed ID: 1300933 [TBL] [Abstract][Full Text] [Related]
9. [Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection]. Ryzhkova VV; Pavlovich NV; Makarovskaia LN; Zurabian VA; Bespalova IA; Goncharov EK; Bugaeva OK; Malsova NN Antibiot Khimioter; 1996 Feb; 41(2):35-9. PubMed ID: 8929117 [TBL] [Abstract][Full Text] [Related]
10. [Combined chemotherapy of experimental infection in neutropenia]. Viadro MM; Ivanitskaia LP; Samoĭlova LN; Kudinova MK; Bodunkova LE Antibiot Khimioter; 1989 May; 34(5):378-82. PubMed ID: 2662929 [TBL] [Abstract][Full Text] [Related]
11. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice]. Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316 [TBL] [Abstract][Full Text] [Related]
12. [Pathomorphological changes in albino mice infected with plague and treated with cefotaxime]. Makarovskaia LN; Sorokina TB; Zurabian VA; Ryzhkova VV; Markovskaia EI Antibiot Khimioter; 1998; 43(3):27-30. PubMed ID: 9606494 [TBL] [Abstract][Full Text] [Related]
13. [Comparative effectiveness of rifampicin for parenteral administration and internal dose in the treatment of experimental plague in albino mice]. Makarovskaia LN; Ryzhkova VV; Zurabian VA; Bugaeva OK; Pasiukov VV; Fomina IP; Navashin SM Antibiot Khimioter; 1995 Jun; 40(6):37-9. PubMed ID: 8593093 [TBL] [Abstract][Full Text] [Related]
14. [Multifactorial experiment on the combined effect of rifampicin and microbial polysaccharide in experimental plague infection]. Nikitin AV; Makarovskaia LN; Fomina IP; Ivanitskaia LP; Popova GO; Vinidchenko NN; Korganov IaN; Gorin SE Antibiot Khimioter; 1991 May; 36(5):25-7. PubMed ID: 1953167 [TBL] [Abstract][Full Text] [Related]
15. [Multifactorial study of the combined effect of rifampicin and microbial peptidoglycan in experimental plague infection]. Nikitin AV; Makarovskaia LN; Fomina IP; Ivanitskaia LP; Popova GO; Vinidchenko NN; Korganov IaN; Bodunkova LE Antibiot Khimioter; 1991 May; 36(5):23-5. PubMed ID: 1953166 [TBL] [Abstract][Full Text] [Related]
16. Experimental endocarditis and fosfomycin. Rodríguez A; Vicente MV; Olay T Drugs Exp Clin Res; 1985; 11(1):55-62. PubMed ID: 3836112 [TBL] [Abstract][Full Text] [Related]
17. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen]. Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704 [TBL] [Abstract][Full Text] [Related]
18. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus]. David C; Chaste A; Saison C; Combremont AG Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735 [TBL] [Abstract][Full Text] [Related]
19. Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics. Schurman DJ; Kajiyama G; Nagel DA J Bone Joint Surg Am; 1980; 62(4):620-7. PubMed ID: 6991503 [TBL] [Abstract][Full Text] [Related]